These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11360642)

  • 1. [DNA content and cell cycle phase analysis in uterine sarcomas and its clinical significance].
    Tan X; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):551-4. PubMed ID: 11360642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of uterine sarcomas.
    Lennart K; Lennart B; Ulf S; Bernard T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
    Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of DNA content and cell cycle in nasopharyngeal carcinoma].
    Liu YF; Zhou GY; Liu YH; Luo F; Liu SX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):212-3. PubMed ID: 15071919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of cellular DNA content in the diagnosis and prognosis of mesenchymal tumors].
    Tóth E; Szentirmay Z
    Orv Hetil; 1996 Nov; 137(45):2511-5. PubMed ID: 8999396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters.
    Stendahl U; Wagenius G; Strang P; Tribukait B
    In Vivo; 1988; 2(2):123-7. PubMed ID: 2979827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of human uterine sarcomas and cell lines.
    Nelson KG; Haskill JS; Sloan S; Siegfried JM; Siegal GP; Walton L; Kaufman DG
    Cancer Res; 1987 Jun; 47(11):2814-20. PubMed ID: 3567904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms.
    Zalupski MM; Ryan JR; Ensley JF; Maciorowski Z; Pietraszkiewicz H; Hussein ME; Kukuruga M; Sundareson AS; Baker LH
    Cytometry; 1993 Nov; 14(8):922-30. PubMed ID: 8287735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
    Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
    Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
    Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
    Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometry analysis of retinoblastoma and its clinical significance].
    Song XJ
    Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):289-92. PubMed ID: 2086141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of nuclear DNA content measurements in pancreatic neoplasms and their Kaplan-Meier survival analysis].
    Sun CY; Zhang YL; Chao SL
    Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):364-6. PubMed ID: 7842963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA analysis of laryngeal carcinoma cells by flow cytometry: the histoclinical factors and their significance.
    Dobroś W; Lackowska B; Ryś J; Niezabitowski A; Stanisz-Wallis K; Olszewski E; Modrzejewski M
    J Otolaryngol; 2000 Dec; 29(6):371-6. PubMed ID: 11770146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.